Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial.

Amy BrennerAntonio BelliRizwana ChaudhriTimothy CoatsLauren FrimleySabariah Faizah JamaluddinRashid JoomaRaoul MansukhaniPeter SandercockHaleema Shakur-StillTemitayo ShokunbiIan Robertsnull null

Published in: Critical care (London, England) (2020)

ISRCTN15088122 , registered on 19 July 2011; NCT01402882 , registered on 26 July 2011.

Keyphrases

study protocol
open label
randomized controlled trial
blood brain barrier
double blind